Abstract

 


 



Counterfeit, Medicines and ACTA


Umang Singh II


National Academy of Legal Studies and Research (NALSAR) University

December 13, 2010


Abstract:     
There has been much confusion about the word counterfeit in the secretly negotiated agreement (ACTA) by the developed nations. The agreement in fact not only covers counterfeits in general but goes on to extend the current IPR protection. It criminalizes various forms of infringements and enhances the border measures which could possibly raise a trade barrier of developing nations. The paper tries to reveal the hidden politics of the first world to negotiate ACTA in first place, taking into light the case of counterfeit medicines whose definition worldwide remains disputed. The need to change the debate from access to medicine to public health and safety which could adversely affect the generic manufacturers as they are caught in between.

Number of Pages in PDF File: 27

Keywords: ACTA, Counterfeit, Counterfeit Medicines, Infrigements, Forum Shopping

working papers series


Download This Paper

Date posted: December 15, 2010  

Suggested Citation

Singh, Umang, Counterfeit, Medicines and ACTA (December 13, 2010). Available at SSRN: http://ssrn.com/abstract=1725072 or http://dx.doi.org/10.2139/ssrn.1725072

Contact Information

Umang Singh II (Contact Author)
National Academy of Legal Studies and Research (NALSAR) University ( email )
3-4-761, Barkatpura
Shameerpet
Hyderabad, Andhra Pradesh 500027
India
Feedback to SSRN (Beta)


Paper statistics
Abstract Views: 571
Downloads: 111
Download Rank: 125,418

© 2013 Social Science Electronic Publishing, Inc. All Rights Reserved.  FAQ   Terms of Use   Privacy Policy   Copyright
This page was processed by apollo6 in 0.453 seconds